CMPO — CompoSecure Income Statement
0.000.00%
- $2.60bn
- $2.47bn
- $420.57m
- 76
- 12
- 98
- 67
Annual income statement for CompoSecure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 268 | 378 | 391 | 421 |
| Cost of Revenue | ||||
| Gross Profit | 145 | 220 | 209 | 219 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 187 | 264 | 272 | 313 |
| Operating Profit | 81.4 | 115 | 119 | 107 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 82.6 | 136 | 117 | -81 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 83.4 | 132 | 113 | -83.2 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 13.5 | 18.7 | 19.2 | -53.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | 13.5 | 18.7 | 34.1 | -53.7 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.142 | 0.573 | 0.965 | -1.17 |
| Special Dividends per Share |